先天性瞳孔残膜的研究进展  

Research progress on persistent pupillary membrane

作　　者：周玲琳 万修华[2] Zhou Linglin;Wan Xiuhua(Department of Ophthalmology,People’s Hospital of Quzhou,Zhejiang 324000,China;Beijing Tongren Eye Center,Beijing Key Laboratory of Ophthalmology and Visual Sciences,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China)

机构地区：[1]浙江省衢州市人民医院眼科中心,324000 [2]首都医科大学附属北京同仁医院、北京同仁眼科中心、眼科学与视觉科学北京市重点实验室,100730

出　　处：《国际眼科纵览》2022年第5期443-448,共6页International Review of Ophthalmology

基　　金：北京市医院管理中心临床医学发展专项经费(XMLX202133);国家自然科学基金(82171037)。

摘　　要：现有研究认为先天性瞳孔残膜发生可能由于巨噬细胞吞噬功能障碍及成纤维母细胞持久的合成活性所致,但也有病例报告认为与母亲在孕期感染性因素相关,其临床形态有较大差异性,对视力的影响也不同。目前对于其治疗,主要根据残膜的大小和对视力有无影响而定,治疗方法包括药物、激光及手术。Existing studies believe that occurrence of persistent pupillary membrane may be caused by macrophage phagocytosis dysfunction and persistent synthetic activity of fibroblasts,but there are also case reports considering which related to maternal infectious factors during pregnancy.Its clinical morphology is quite different,and its impact on vision is also different.At present,its treatment is mainly based on the size of the residual membrane and whether it affects vision.The treatment methods mainly include drugs,lasers and surgery.

关 键 词：先天性瞳孔残膜 

分 类 号：R773.2[医药卫生—眼科]